Table Of Content

CANCER LETTERS EPLUSBELVIISEHRE RSS CIIERNETILFAINCD Cancer Letters 75 (1993) 207-208 Subject index Volume 75 Activated lymphocyte, progesterone, interleukin 2, 157 Differential expression, bladder carcinoma, cytokeratin, 87 Apoptosis, monoclonal antibody, leukemia cells, metabolism, Differentiation marker, HER-2/neu, esophageal adenocarcino- microcalorimetry, 103 ma, 41 Aromatase, breast cancer, tobacco alkaloid, inhibitor, estrogen DNA 5-methylcytosine, mouse liver tumor, Ha-ras, methyla- biosynthesis, 175 tion, oncogene, 129 Azoxymethane, wheat bran fiber, psyllium fiber, 53 DNA alkyltransferase, estrous cycle, O°-methylguanine-DNA- methyltransferase, 11 Bladder cancer, schistosomiasis, hycanthone, metrifonate, ox- DNA methylation damage, schistosomiasis, hycanthone, aminiquine, DNA methylation damage, DNA repair, 167 metrifonate, oxaminiquine, bladder cancer, DNA repair, Bladder carcinoma, cytokeratin, differential expression, 87 167 Breast cancer, aromatase, tobacco alkaloid, inhibitor, estrogen DNA repair, schistosomiasis, hycanthone, metrifonate, ox- biosynthesis, 175 aminiquine, bladder cancer, DNA methylation damage, 167 Breast cancer, fatty acids, invasion, 137 Dominant negative mutation, ras oncogene, tumor suppres- Breast cancer, HER-2/neu, p185, steroid receptors, cathepsin sion, 19 D, 195 Dose level limit, carcinogenic potency, rodents, humans, 183 Breast carcinoma, FSH, fibrocystic diseases, | Drug resistance, cisplatin, small cell lung cancer, glutathione, glutathione S-transferase, 111 c-myc, rat colon carcinogenesis, cell proliferation, magnesium Esophagea! adenocarcinoma, HER-2/neu, differentiation hydroxide, methylazoxymethanol acetate, 73 marker, 41 C3 activation products, ricin A chain, ricin Estrogen biosynthesis, aromatase, breast cancer, tobacco alka- B chain, terminal SC56-9 complement complex, 59 loid, inhibitor, 175 cadmium, lung, cancer, metallothionein, copper, 121 Estrous cycle, O°-methylguanine-DNA-methyltransferase, Cancer, HT-29-D4 cells, suramin, polarity, lysosomal disorder, DNA alkyltransferase, 11 quantitative autoradiography, 151 Cancer, lung, metallothionein, copper, cadmium, 121 Fatty acids, breast cancer, invasion, 137 Capsaicin, cytochrome P450, metabolism, NNK, 45 Fibrocystic diseases, FSH, breast carcinoma, | 5-Fluorouracil, Carcinogenesis, inositol hexaphosphate, Sprague—Dawley rats, renal cell cancer, lymphokine-activated killer cell, 27 pilot study, 95 FSH, breast carcinoma, fibrocystic diseases, | Carcinogenic potency, rodents, humans, dose level limit, 183 Cathepsin D, breast cancer, HER-2/neu, p185, steroid recep- Glutathione, cisplatin, small cell lung cancer, drug resistance, tors, 195 glutathione S-transferase, 111 Cell proliferation, c-myc, rat colon carcinogenesis, magnesium Glutathione S-transferase, cisplatin, small cell lung cancer, hydroxide, methylazoxymethanol acetate, 73 drug resistance, glutathione, 111 Cisplatin, small cell lung cancer, drug resistance, glutathione, glutathione S-transferase, 111 Ha-ras, mouse liver tumor, methylation, DNA 5- Combination therapy, tumor-induced angiogenesis, retinoids, methylcytosine, oncogene, 129 vitamin D,, 35 Hematoporphyrins, photodynamic therapy. intravesical instil- Copper, lung, cancer, metallothionein, cadmium, 121 lation, 65 Cytochrome P450, capsaicin, metabolism, NNK, 45 HER-2/neu, differentiation marker, esophageal adenocarcino- Cytokeratin, bladder carcinoma, differential expression, 87 ma, 41 208 Subject index /C ancer Lett. 75 (1993) 207-208 HER-2/neu, breast cancer, p185, steroid receptors, cathepsin D, p185, breast cancer, HER-2/neu, steroid receptors, cathepsin D, 195 195 HT-29-D4 cells, cancer, suramin, polarity, lysosomal disoder, quantitative autoradiography, 151 Photodynamic therapy, hematoporphyrins, intravesical instil- Human colorectal tumor, a@2,6-sialyltransferase, metastasis, lation, 65 serum determinations, tumor monitoring, 143 Pilot study, carcinogenesis, inositol hexaphosphate, Humans, carcinogenic potency, rodents, dose level limit, 183 Sprague-Dawley rats, 95 Hycanthone, schistosomiasis, metrifonate, oxaminiquine, blad- Polarity, HT-29-D4 cells, cancer, suramin, lysosomal disorder, der cancer, DNA methylation damage, DNA repair, 167 quantitative autoradiography, 151 Progesterone, interleukin 2, activated lymphocyte, 157 Inhibitor, aromatase, breast cancer, tobacco alkaloid, estrogen Psyllium fiber, azoxymethane, wheat bran fiber, 53 biosynthesis, 175 Inositol hexaphosphate, carcinogenesis, Sprague-Dawley rats, Quantitative autoradiography, HT-29-D4 cells, cancer, pilot study, 95 suramin, polarity, lysosomal disorder, 151 Interleukin 2, progesterone, activated lymphocyte, 157 Intravesical instillation, photodynamic therapy, hematopor- ras oncogene, dominant negative mutation, tumor suppression, phyrins, 65 19 Invasion, breast cancer, fatty acids, 137 Rat colon carcinogenesis, c-myc, cell proliferation, magnesium hydroxide, methylazoxymethanol acetate, 73 Leukemia cells, monoclonal antibody, apoptosis, metabolism, Renal cell cancer, 5-fluorouracil, lymphokine-activated killer microcalorimetry, 103 cell, 27 Lung, cancer, metallothionein, copper, cadmium, 121 Retinoids, tumor-induced angiogenesis, vitamin D3, combina- Lung cancer, vasopressin, oxytocin, neurophysin, 79 tion therapy, 35 Lymphokine-activated killer cell, 5-fluorouracil, renal cell Ricin A chain, ricin B chain, C3 activation products, terminal cancer, 27 SC56-9 complement complex, 59 Lysosomal disorder, HT-29-D4 cells, cancer, suramin, polarity, Ricin B chain, ricin A chain, C3 activation products, terminal quantitative autoradiography, 151 SC56-9 complement complex, 59 Rodents, carcinogenic potency, humans, dose level limit, 183 Magnesium hydroxide, c-myc, rat colon carcinogenesis, cell proliferation, methylazoxymethanol acetate, 73 Schistosomiasis, hycanthone, metrifonate, oxaminiquine, blad- Metabolism, capsaicin, cytochrome P450, NNK, 45 der cancer, DNA methylation damage, DNA repair, 167 Metabolism, monoclonal antibody, apoptosis, leukemia cells, Serum determinations, a2,6-sialyltransferase, human colorectal microcalorimetry, 103 tumor, metastasis, tumor monitoring, 143 Metallotionein, lung, cancer, copper, cadmium, 121 a2,6-sialyltransferase, human colorectal tumor, metastasis, Metastasis, a2,6-sialyltransferase, human colorectal tumor, serum determinations, tumor monitoring, 143 serum determinations, tumor monitoring, 143 Small cell lung cancer, cisplatin, drug resistance, glutathione, Methylation, mouse liver tumor, Ha-ras, DNA 5-methyl- glutathione S-transferase, 111 cytosine, oncogene, 129 Sprague-Dawley rats, carcinogenesis, inositol hexaphosphate, Methylazoxymethanol acetate, c-myc, rat colon carcinogenesis, pilot study, 95 cell proliferation, magnesium hydroxide, 73 Steroid receptors, breast cancer, HER-2/neu, p185, cathepsin Metrifonate, schistosomiasis, hycanthone, oxaminiquine, blad- D, 195 der cancer, DNA methylation damage, DNA repair, 167 Suramin, HT-29-D4 cells, cancer, polarity, lysosomal disorder, Microcalorimetry, monoclonal antibody, apoptosis, leukemia quantitative autoradiography, 151 cells, metabolism, 103 Monoclonal antibody, apoptosis, leukemia cells, metabolism, Terminal SC56-9 complement complex, ricin A chain, ricin B microcalorimetry, 103 chain, C3 activation products, 59 Mouse liver tumor, Ha-ras, methylation, DNA 5-methyl- Tobacco alkaloid, aromatase, breast cancer, inhibitor, estrogen cytosine, oncogene, 129 biosynthesis, 175 Tumor monitoring, @2,6-sialyltransferase, human colorectal Neurophysin, vasopressin, oxytocin, lung cancer, 79 tumor, metastasis, serum determinations, 143 NNK, capsaicin, cytochrome P450, metabolism, 45 Tumor suppression, dominant negative mutation, ras oncogene, 19 O°-methylguanine-DNA-methyltransferase, estrous cycle, Tumor-induced angiogenesis, retinoids, vitamin D,, combina- DNA alkyltransferase, 11 tion therapy, 35 Oncogene, mouse liver tumor, Ha-ras, methylation, DNA 5- Vasopressin, oxytocin, neurophysin, lung cancer, 79 methylcytosine, 129 Vitamin D,, tumor-induced angiogenesis, retinoids, combina- Oxaminiquine, schistosomiasis, hycanthone, metrifonate, blad- tion therapy, 35 der cancer, DNA methylation damage, DNA repair, 167 Oxytocin, vasopressin, neurophysin, lung cancer, 79 Wheat bran fiber, azoxymethane, psyllium fiber, 53 > CANCER Bis LETTERS ELSEVIER SCIENTIFIC P - PUBLISHERS IRELAND Cancer Letters 75 (1993) 209-210 Author index Volume 75 Alabaster, O. Hetland, G. Anderson, C.H. Hussain, R.A. Awasthi, S. Hwang, Y.-W. Awney, H.H. Axelsson, B. Imai, T. Badawi, A.F. Jablonska, S. Baghdiguian, S. Joseph, R. Bajpai, K.K. Baker, V. Kadohama, N. Bansal, M. Kameyama, S. Barker, S. Katagiri, A. Beattie, C.W. Kawamata, H. Bollag, W. Keller, S.M. Borrebaeck, C.A.K. Kemmner, W. Boudier, J.-A. Kimoto, Y. Boudier, J.-L. Kimura, M. Kuzumaki, N. Chang, B.-D. Chinoy, R.F. Leo, G. Ciardo, V. Lofgren, L. Connolly, J.M. Lonnbro, P. Counts, J.L. Majewski, S. Davies, T.S. Marczak, M. Marsigliante, Erner, S. Memoli, V.A. Miller, C.H. Fantini, J. Moan, J. Frenkel, E.P. Mollnes, T.E. Friedmann, A.S. Monro, A. Frost, A. Mori, H. Mostafa, M.H. Garde, S.V. Mottaghi, A. Garred, P. Muscella, A. GeBner, P. Goldberg, M. Nan, L. Goodman, J.I. North, W.G. Hamilton, S.M. Ogiso, Y. Hart, B.A. Osawa, Y. Hellsten, S. Oyasu, R. 210 futhor index /C ancer Lett. 75 (1993) 209-210 Panchal, C.J. Storelli, C. Peng, Q. Szmurlo, A. Quentmaier, A. Taguchi, T. Tan, X. Riedl, S. Tanaka, T. Rose, D.P. Tang, Z.C. Teel, R.W. Saitoh, K. Tomita, Y Sakamoto, K. Tong, F.-Z. Sato, S. Vacek, P.M. Sauter, E.R. Vinson, G.P. Schon, A. Voss, G.W Shamsuddin, A.M. Vucenik, I. Sharma, R. Sheth, A.R. Wallén-Ohman, M. Sheth, N.A. Wang, A. Shih, T.Y. Windahl, T. Shintani, K. Shivapurkar, N. Yoshimi, N. Singhal, S.S. Srivastava, S.K. Zhang, Z.